Smith Stan

Smith Stan is listed in filings as Director at MAIA Biotechnology, Inc.. This profile follows SEC Form 4 activity through Jun 2, 2026, including purchase activity. Recent filings connect the profile to MAIA Biotechnology, Inc. (MAIA). The current snapshot covers public activity from Jul 2, 2024 to Jun 2, 2026. Reported amounts are shown as $100.2K to $44.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.